the paradoxical bronchoconstriction observed with commercially available isotonic ipratropium bromide nebuliser solution ( atrovent ) in patients with asthma results from an adverse reaction to the preservatives , benzalkonium chloride and ethylenediaminetetra-acetic acid ( edta ) .
C0700580
ipratropium bromide
C0591130
atrovent